Author

John E. Locke

Kennedy Krieger Institute

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Elizabeth Anne Kolar· 1 shared Emily M. Clay· 1 shared Mayur D. ModyiD· 1 shared Paul A. WatkinsiD· 1 shared Xiaohai ShiiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

5 top collaborators · 10 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

Elizabeth Anne Kolar

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Toward pharmacologic therapy for glioblastoma: Identifying inhibitors of very long-chain acyl-CoA synthetase 3 (ACSVL3)

Emily M. Clay, Xiaohai Shi, Elizabeth Anne Kolar, Mayur D. Mody, John E. Locke, Paul A. Watkins

This paper identifies potential inhibitors of ACSVL3, an enzyme overexpressed in glioblastoma, using in vitro assays and a high-throughput screening approach.

bioRxiv · Jul 2, 2025 · PreprintBiochemistry